These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27146666)

  • 1. Elevated inflammatory markers predict mortality in long-term ischemic stroke-survivors: a population-based prospective study.
    Frøyshov HM; Bjørnerem Å; Engstad T; Halvorsen DS
    Aging Clin Exp Res; 2017 Jun; 29(3):379-385. PubMed ID: 27146666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
    Di Napoli M; Papa F;
    Stroke; 2002 Jul; 33(7):1763-71. PubMed ID: 12105349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke.
    Li YM; Liu XY
    J Neurol Sci; 2015 May; 352(1-2):68-73. PubMed ID: 25868898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients.
    Naess H; Nyland H; Idicula T; Waje-Andreassen U
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e435-40. PubMed ID: 23735372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
    ; Kaptoge S; Di Angelantonio E; Lowe G; Pepys MB; Thompson SG; Collins R; Danesh J
    Lancet; 2010 Jan; 375(9709):132-40. PubMed ID: 20031199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004).
    Koton S; Tanne D; Green MS; Bornstein NM
    Neuroepidemiology; 2010; 34(2):90-6. PubMed ID: 20016218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
    Nyrnes A; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Skjelbakken T; Jørgensen L; Løchen ML
    Gend Med; 2012 Dec; 9(6):536-547.e2. PubMed ID: 23046763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
    Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.
    Bickel C; Rupprecht HJ; Blankenberg S; Espiniola-Klein C; Schlitt A; Rippin G; Hafner G; Treude R; Othman H; Hofmann KP; Meyer J;
    Am J Cardiol; 2002 Apr; 89(8):901-8. PubMed ID: 11950425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.
    Whiteley W; Jackson C; Lewis S; Lowe G; Rumley A; Sandercock P; Wardlaw J; Dennis M; Sudlow C
    Stroke; 2011 Jan; 42(1):10-6. PubMed ID: 21127302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin Is a Stronger Predictor of Long-Term Functional Outcome and Mortality than High-Sensitivity C-Reactive Protein in Patients with Ischemic Stroke.
    Wang C; Gao L; Zhang ZG; Li YQ; Yang YL; Chang T; Zheng LL; Zhang XY; Man MH; Li LH
    Mol Neurobiol; 2016 Apr; 53(3):1509-1517. PubMed ID: 25650122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study.
    Ahmadi-Abhari S; Luben RN; Wareham NJ; Khaw KT
    Eur J Epidemiol; 2013 Jul; 28(7):541-50. PubMed ID: 23821244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
    Everett BM; Kurth T; Buring JE; Ridker PM
    J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study.
    Bos MJ; Schipper CM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
    Circulation; 2006 Oct; 114(15):1591-8. PubMed ID: 17015791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-inflammatory, oxidative stress and biochemical biomarkers predict short-term acute ischemic stroke death.
    Reiche EMV; Gelinksi JR; Alfieri DF; Flauzino T; Lehmann MF; de Araújo MCM; Lozovoy MAB; Simão ANC; de Almeida ERD; Maes M
    Metab Brain Dis; 2019 Jun; 34(3):789-804. PubMed ID: 30875023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Inflammatory Biomarkers for Myocardial Infarction Risk: A Prospective Community-Based Study.
    Wu Z; Huang Z; Jin W; Rimm EB; Lichtenstein AH; Kris-Etherton PM; Wu S; Gao X
    Clin Chem; 2017 Mar; 63(3):663-672. PubMed ID: 28031418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
    Depalma RG; Hayes VW; Chow BK; Shamayeva G; May PE; Zacharski LR
    J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population.
    Makita S; Nakamura M; Satoh K; Tanaka F; Onoda T; Kawamura K; Ohsawa M; Tanno K; Itai K; Sakata K; Okayama A; Terayama Y; Yoshida Y; Ogawa A
    Atherosclerosis; 2009 May; 204(1):234-8. PubMed ID: 18790479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.